GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 116 filers reported holding GOSSAMER BIO INC in Q2 2021. The put-call ratio across all filers is 7.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $38,317,000 | +2208.3% | 3,198,382 | +1512.2% | 2.68% | +2025.4% |
| Q2 2022 | $1,660,000 | -3.6% | 198,382 | 0.0% | 0.13% | -4.5% |
| Q1 2022 | $1,722,000 | -23.3% | 198,382 | 0.0% | 0.13% | -0.8% |
| Q4 2021 | $2,244,000 | -10.0% | 198,382 | 0.0% | 0.13% | +31.7% |
| Q3 2021 | $2,494,000 | +54.8% | 198,382 | 0.0% | 0.10% | +83.6% |
| Q2 2021 | $1,611,000 | -79.5% | 198,382 | -76.6% | 0.06% | -68.6% |
| Q1 2021 | $7,848,000 | -4.3% | 848,382 | 0.0% | 0.18% | -10.3% |
| Q4 2020 | $8,204,000 | +166.2% | 848,382 | +241.6% | 0.20% | +63.9% |
| Q3 2020 | $3,082,000 | -32.1% | 248,382 | -28.9% | 0.12% | -31.2% |
| Q2 2020 | $4,541,000 | +125.5% | 349,325 | +76.1% | 0.17% | +84.0% |
| Q1 2020 | $2,014,000 | -57.0% | 198,382 | -33.9% | 0.09% | -49.7% |
| Q4 2019 | $4,689,000 | -54.8% | 300,000 | -51.5% | 0.19% | -70.4% |
| Q3 2019 | $10,378,000 | -27.2% | 618,129 | -3.9% | 0.63% | -22.8% |
| Q2 2019 | $14,265,000 | +0.8% | 643,129 | -1.5% | 0.82% | -14.4% |
| Q1 2019 | $14,153,000 | – | 653,129 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
| Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
| Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
| Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
| HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
| Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
| Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
| Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
| Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
| Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |